New drug may rescue voice after botox side effect.
NCT ID NCT05123053
Summary
This study tested a drug called amifampridine to see if it could reduce temporary voice weakness and breathiness that often occurs in the weeks after people receive Botox injections for a voice disorder called spasmodic dysphonia. The trial involved 18 adults who experienced significant breathiness after their standard Botox treatment. Researchers measured if the drug improved patients' self-reported voice problems using a standard questionnaire.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VOCAL WEAKNESS(POST-BOTOX INJECTION) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Augusta University
Augusta, Georgia, 30912, United States
Conditions
Explore the condition pages connected to this study.